The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N-dibenzyl-2-(4-(N-isobutylsulfamoyl)phenoxy)acetamide ID: ALA4434895
PubChem CID: 126200721
Max Phase: Preclinical
Molecular Formula: C26H30N2O4S
Molecular Weight: 466.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)CNS(=O)(=O)c1ccc(OCC(=O)N(Cc2ccccc2)Cc2ccccc2)cc1
Standard InChI: InChI=1S/C26H30N2O4S/c1-21(2)17-27-33(30,31)25-15-13-24(14-16-25)32-20-26(29)28(18-22-9-5-3-6-10-22)19-23-11-7-4-8-12-23/h3-16,21,27H,17-20H2,1-2H3
Standard InChI Key: CJJPIMDYJRXNIG-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
34.5209 -18.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.1125 -19.6667 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.9373 -19.6620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2527 -18.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2516 -19.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9664 -19.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6828 -19.2851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6800 -18.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9646 -18.0455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3929 -18.0395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1089 -18.4493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8219 -18.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1121 -19.2742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8280 -19.6841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8296 -20.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5447 -20.9191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2586 -20.5039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2528 -19.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5371 -19.2687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5379 -18.4439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8188 -17.2091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2508 -18.0288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9668 -18.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9670 -19.2636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6822 -19.6733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3961 -19.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3904 -18.4288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6746 -18.0228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1168 -20.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8335 -20.9006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8379 -21.7257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5545 -22.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1255 -22.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 1 0
12 21 2 0
20 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 2 1 0
2 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
31 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 466.60Molecular Weight (Monoisotopic): 466.1926AlogP: 4.23#Rotatable Bonds: 11Polar Surface Area: 75.71Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.43CX Basic pKa: ┄CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -1.32
References 1. Wu DM, Wang YJ, Fan SH, Zhang ZF, Shan Q, Lu J, Chen GQ, Zheng YL.. (2019) High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity., 164 [PMID:30597326 ] [10.1016/j.ejmech.2018.12.051 ] 2. Wu DM, Wang YJ, Fan SH, Zhang ZF, Shan Q, Lu J, Chen GQ, Zheng YL.. (2019) High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity., 164 [PMID:30597326 ] [10.1016/j.ejmech.2018.12.051 ]